|
AgeneraseDrug - Agenerase The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Amprenavir
Strength -
150MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
021007
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 15, 1999
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Agenerase
Polycillin Eq 125mg Base Tablet, Chewable; Oral
Principen W/ Probenecid Eq 389mg Base;111mg Capsule; Oral Principen W/ Probenecid Eq 389mg Base;111mg Capsule; Oral Polycillin-prb Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Polycillin-prb Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Probampacin Eq 3.5gm Base/bot;1gm/bot For Suspension; Oral Agenerase 150mg Capsule; Oral Totacillin Eq 125mg Base/5ml For Suspension; Oral Totacillin Eq 250mg Base/5ml For Suspension; Oral Totacillin Eq 250mg Base/5ml For Suspension; Oral NewDrugInformation |